experts debate the pros and cons of treating subclinical hypothyroidism or hyperthyroidism

June 2012

You'll hear experts debate the pros and cons of treating subclinical hypothyroidism or hyperthyroidism.

There are good points on both sides.

Subclinical HYPOthyroidism is associated with an increased risk of ischemic heart disease, cardiovascular events, and mortality.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote